Clinical ResearchInvasive and Interventional CardiologyImpact of Delay to Angioplasty in Patients With Acute Coronary Syndromes Undergoing Invasive Management: Analysis From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial
Invasive and Interventional Cardiology
Under an Elsevier user license
open archive
Key Words
acute coronary syndrome
PCI
timing
Abbreviations and Acronyms
CABG
coronary artery bypass grafting
MI
myocardial infarction
NSTE-ACS
non–ST-segment elevation acute coronary syndrome
PCI
percutaneous coronary intervention
TIMI
Thrombolysis In Myocardial Infarction
Cited by (0)
Dr. Gersh is a member of the Data Safety Monitoring Board for Boston Scientific, Abbott Laboratories, Bristol-Myers Squibb, and AstraZeneca, and is a stock shareholder for CV Therapeutics. Dr. Tcheng is on the Scientific Board for Schering-Plough, and on the Speakers' Bureau for Schering-Plough and Eli Lilly. Dr. Stone is on the advisory board for Abbott Vascular and Boston Scientific.
Copyright © 2010 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.